PHOSPLATIN THERAPEUTICS INC.

Profile

Company Names

PHOSPLATIN THERAPEUTICS INC.
PHOSPLATIN THERAPEUTICS LLC

Addresses

1350 AVENUE OF THE AMERICAS, 23RD FLOOR, NEW YORK, NY 10019

1350 AVENUE OF THE AMERICAS, 23RD FLOOR, NEW YORK, NY 10019

1350 AVENUE OF THE AMERICAS, 3RD FL., NEW YORK, NY 10019

Phone Numbers

646-380-2441

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$72,300,619.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2021-12-03 
$37,295,619.00 
$37,295,619.00 
$0.00 
Equity 
2
2020-07-31 
$18,400,000.00 
$18,400,000.00 
$0.00 
Debt 
1
2018-10-31 
$16,605,000.00 
$16,605,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FRANCES 
 
BONHAM 
EXECUTIVE OFFICER
PHOSPLATIN THERAPEUTICS LLC   |  PHOSPLATIN THERAPEUTICS INC.
JOHN 
 
CAOUETTE 
DIRECTOR
PHOSPLATIN THERAPEUTICS LLC   |  PHOSPLATIN THERAPEUTICS INC.
PETER 
 
ESPIG 
DIRECTOR
NOVADX VENTURES CORP.   |  HULDRA SILVER INC.   |  PHOSPLATIN THERAPEUTICS LLC   |  PHOSPLATIN THERAPEUTICS INC.   |  ESGOLD CORP.   |  NICOLA MINING INC.
ROBERT 
 
FALLON 
EXECUTIVE OFFICER, DIRECTOR
PHOSPLATIN THERAPEUTICS LLC   |  PHOSPLATIN THERAPEUTICS INC.
ROSITA 
 
LEONG 
DIRECTOR
PHOSPLATIN THERAPEUTICS LLC   |  PHOSPLATIN THERAPEUTICS INC.
JOHN 
 
PORTER 
DIRECTOR
DECISIONLINK CORP   |  AZTHERAPIES, INC   |  PHOSPLATIN THERAPEUTICS LLC   |  PILOSA CORP.   |  MOLECULA CORP.   |  SAVI SOLUTION, INC.
MATTHEW 
 
PRICE 
DIRECTOR, EXECUTIVE OFFICER
PHOSPLATIN THERAPEUTICS LLC   |  WVV THOMASVILLE HOLDINGS LLC   |  L2LP EIG, LLC   |  PHOSPLATIN THERAPEUTICS INC.   |  WV VENTURES LLC   |  CRESCENDOAI INC.   |  LIZTON FINANCIAL CORP
FALLON 
 
ROBERT 
EXECUTIVE OFFICER, DIRECTOR
PHOSPLATIN THERAPEUTICS LLC
CHARLES 
 
STUCKEY 
DIRECTOR
PHOSPLATIN THERAPEUTICS INC.
NEIL 
 
SUNDERLAND 
DIRECTOR
INDUSTRIAL ORIGAMI INC   |  INDUSTRIAL ORIGAMI, INC.   |  PHOSPLATIN THERAPEUTICS LLC   |  PHOSPLATIN THERAPEUTICS INC.
ELIZABETH 
 
TALLETT 
DIRECTOR
Y-PRIME, INC.   |  PHOSPLATIN THERAPEUTICS INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-12-15
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-03 
2020-08-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2020-07-31 
2018-11-08
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-10-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#